(Bloomberg Gadfly) -- Congratulations, Abbott Labs! You’ve won a not-so-shiny and not-so-new takeover!
The medical-device maker this week received all the regulatory approvals necessary to proceed with its contentious purchase of test-maker Alere Inc. Abbott now expects the transaction, which will require divestitures of Alere’s blood-gas and cardiac-marker testing systems, to close on Oct. 3.
